Our company are one leading API producer and exporter in China, COS and FDA site inspection approval for some of our APIs. We are exporting our products to around 50 countries currenly, with regular customers as GSK, Abbott, Sanofi-Aventis and etc...It would be our great pleasure and honor to work together with you and your esteemed company.

Established in 2002, with the registered capital RMB5, 000, 000, Wuhan Biocause Pharmaceutical Development Co., Ltd is one of the subsidiaries of the Tianmao Industrial Investment Co., ltd, which was named as Hubei Biocause Pharmaceutical Co., Ltd before, listed in Shenzhen stock market under listing tick 000627The company located in the Hi-tech Industrial Park of Wuhan Economic &Technologic Development Zone, which occupy about 1884 square meters, including 4 synthesis lab, 2 analytical lab, 4 Class 10000 clean room and 1 Class 100 microbiology labs.